Phase III Study of the Efficacy and Safety of Subcutaneous Versus Intravenous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis

OBJECTIVE: To evaluate the efficacious noninferiority of subcutaneous tocilizumab injection (TCZ-SC) monotherapy to intravenous TCZ infusion (TCZ-IV) monotherapy in Japanese patients with rheumatoid arthritis (RA) with an inadequate response to synthetic and/or biologic disease-modifying antirheumat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Arthritis Care Res (Hoboken)
Autors principals: Ogata, Atsushi, Tanimura, Kazuhide, Sugimoto, Toyohiko, Inoue, Hiroshi, Urata, Yukitomo, Matsubara, Tsukasa, Kondo, Masakazu, Ueki, Yukitaka, Iwahashi, Mitsuhiro, Tohma, Shigeto, Ohta, Shuji, Saeki, Yukihiko, Tanaka, Toshio
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2014
Matèries:
Rheumatoid Arthritis
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4225471/
https://ncbi.nlm.nih.gov/pubmed/23983039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acr.22110
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars